OCV
OCV Management LLC is a Los Angeles based investment adviser co-founded by Richard Ressler and Mark Yung in 2016. The firm leverages an investment strategy deployed successfully since 1993 and a team of seasoned professionals who have worked together for an average of 19 years. OCV invests in companies with differentiated technologies and compelling target markets, with the objective of assisting companies create sustainable long-term value. As partners, OCV provides operational and financial... expertise through its experienced principals, who have proven success as entrepreneurs, business leaders and investors across a variety of sectors including technology, healthcare, industrials, real estate and finance. OCV invests across all stages of a company’s growth cycle, and finds creative investment solutions to fit a company’s needs. For more information, visit http://www.ocvpartners.com.
OCV
Industry:
Financial Services Venture Capital
Founded:
2016-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content
Similar Organizations
1843 Capital
Early stage, technology venture capital fund
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-28 | Ozette Technologies | OCV investment in Series A - Ozette Technologies | 26 M USD |
| 2022-01-05 | Ockam | OCV investment in Series A - Ockam | 12.5 M USD |
| 2021-11-10 | Rad AI | OCV investment in Series A - Rad AI | 25 M USD |
| 2021-07-26 | ByHeart | OCV investment in Series B - ByHeart | 90 M USD |
| 2021-04-21 | Orca AI | OCV investment in Seed Round - Orca AI | 13 M USD |
| 2020-09-17 | Finch Therapeutics | OCV investment in Series D - Finch Therapeutics | 90 M USD |
| 2020-07-28 | Praxis Precision Medicines | OCV investment in Series C - Praxis Precision Medicines | 110 M USD |
| 2020-04-15 | ByHeart | OCV investment in Series A - ByHeart | 70 M USD |
| 2020-04-15 | SafeBreach | OCV investment in Series C - SafeBreach | 19 M USD |
| 2019-08-21 | Finch Therapeutics | OCV investment in Series C - Finch Therapeutics | 53.47 M USD |